The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.98
Bid: 6.52
Ask: 6.98
Change: 0.13 (1.90%)
Spread: 0.46 (7.055%)
Open: 6.98
High: 6.98
Low: 6.98
Prev. Close: 6.85
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

22 Jul 2014 11:08

RNS Number : 9756M
Synairgen plc
22 July 2014
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Synairgen plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

IP Group plc

4. Full name of shareholder(s)  (if different from 3.):iv

See section 9

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

18 July 2014

6. Date on which issuer notified:

21 July 2014

7. Threshold(s) that is/are crossed orreached: vi, vii

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1p Shares

 

 

14,269,284

 

 

14,269,284

Below 3%

GB00B0381Z20

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

Below 3%

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Direct interests:

 

IP2IPO Limited and IP2IPO Management Limited, both 100% owned subsidiaries of IP Group plc.

 

Indirect interests:

 

IP Venture Fund, a limited partnership fund that is managed by Top Technology Ventures Limited, a 100% subsidiary of IP Group plc.

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Greg Smith

15. Contact telephone number:

020 7444 0050

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFIIDRIFFIS
Date   Source Headline
22nd Apr 20155:03 pmRNSPosting of Annual Report and Accounts
5th Mar 201512:55 pmRNSRichard Griffiths increases stake to 6.1 percent
3rd Mar 20157:00 amRNSPreliminary Results
12th Feb 201512:44 pmRNSHolding(s) in Company
11th Nov 20142:34 pmRNSExercise of options
4th Nov 20147:00 amRNSGrant of Options
8th Oct 20147:00 amRNSExercise of options
25th Sep 20147:00 amRNSInterim results for the six months ended 30 June
17th Sep 20147:00 amRNSNotice of Interim Results
22nd Jul 20145:23 pmRNSHolding(s) in Company
22nd Jul 201411:11 amRNSHolding(s) in Company
22nd Jul 201411:08 amRNSHolding(s) in Company
21st Jul 20143:53 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSHolding(s) in Company
15th Jul 20143:13 pmRNSHolding(s) in Company
4th Jul 20142:44 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSPlacing
25th Jun 20147:00 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSLicence deal with AstraZeneca
9th Jun 20141:00 pmRNSResult of AGM
16th May 20147:00 amRNSNotice of AGM
9th May 20142:57 pmRNSNotice of Report and Accounts
20th Mar 20147:00 amRNSPreliminary Results
11th Mar 20145:05 pmRNSHolding(s) in Company
6th Mar 201412:58 pmRNSHolding(s) in Company
5th Mar 20147:00 amRNSLicensing Update, Placing & Notice of results
14th Oct 20139:05 amRNSExercise of Options
12th Aug 20137:00 amRNSHalf Yearly Report
18th Jul 20137:00 amRNSPositive anti-inflammatory and anti-viral data
3rd Jul 20133:05 pmRNSHolding(s) in Company
10th Jun 20131:45 pmRNSResult of AGM
21st May 201311:10 amRNSHolding(s) in Company
9th May 201312:45 pmRNSNotice of AGM
9th Apr 20134:26 pmRNSPosting of Annual Report
12th Mar 20137:00 amRNSGrant of Options
13th Feb 20137:00 amRNSPreliminary Results
5th Dec 20127:00 amRNSTrading Update
30th Oct 20121:44 pmRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSExercise of Options
31st Aug 20127:00 amRNSSynairgen presents proof of concept study
10th Aug 20127:00 amRNSHalf Yearly Report
18th Jul 20127:00 amRNSPlacing
25th Jun 20121:30 pmRNSResult of AGM
22nd May 20127:30 amRNSProfessor Stephen Holgate given prestigious Award
1st May 201212:55 pmRNSHolding(s) in Company
19th Apr 20127:00 amRNSPositive Phase II asthma data
2nd Mar 20127:00 amRNSNotice of Report and Accounts
1st Feb 20127:00 amRNSPreliminary results
30th Jan 20127:00 amRNSNotice of Results
12th Dec 20117:00 amRNSDirector's dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.